SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-245437
Filing Date
2012-05-24
Accepted
2012-05-23 18:50:10
Documents
4
Period of Report
2012-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d354917d8k.htm 8-K 73798
2 FIRST AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF AMGEN INC. d354917dex31.htm EX-3.1 1842
3 PRESS RELEASE d354917dex991.htm EX-99.1 12078
4 GRAPHIC g354917ex99_1pg001.jpg GRAPHIC 13745
  Complete submission text file 0001193125-12-245437.txt   108270
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 12865420
SIC: 2836 Biological Products, (No Diagnostic Substances)